PARP Inhibitor Plus Temozolomide Shows Promise in Relapsed Small-Cell Lung Cancer Trial
A phase Ib/II trial in China found that the oral PARP inhibitor HTMC0435 combined with temozolomide produced a manageable safety ...
A phase Ib/II trial in China found that the oral PARP inhibitor HTMC0435 combined with temozolomide produced a manageable safety ...
A Ghanaian randomized trial found that a four-week high-dose rifampicin and clarithromycin regimen was well tolerated for Buruli ulcer but ...
A randomized trial found that high-dose LSD treatment significantly increased working memory-related brain activity in patients with major depressive disorder, ...
A single-arm Japanese study found that a multimodal program of acupuncture and moxibustion significantly reduced persistent taxane-related nerve pain in ...
An international randomised trial found that adding weekly oral methotrexate to prednisolone did not reduce flares or steroid requirements in ...
In a UK first, doctors in Edinburgh have transplanted frozen testicular tissue into a young man left infertile by chemotherapy, ...
A five-year clinical cohort study shows that an optogenetic therapy combining gene injection and light-stimulating goggles is safe and enabled ...
A new clinical study shows that blocking the enzyme ketohexokinase, the gateway of fructose metabolism, improves fatty liver and insulin ...
A randomized crossover trial shows that six weeks of ketohexokinase inhibition improved hepatic and whole-body insulin sensitivity in people with ...
USC researchers have launched an ARPA-H-funded clinical trial testing whether an eight-week mindfulness training program can enhance and sustain the ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine